Cytosorbents (CTSO) News Today $0.92 -0.04 (-4.18%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Contrasting Cytosorbents (NASDAQ:CTSO) & GBS (NYSE:GBS)November 19 at 2:59 AM | americanbankingnews.comFY2024 EPS Forecast for Cytosorbents Decreased by AnalystNovember 16, 2024 | americanbankingnews.comCytosorbents FY2024 EPS Forecast Reduced by HC WainwrightCytosorbents Co. (NASDAQ:CTSO - Free Report) - Stock analysts at HC Wainwright decreased their FY2024 earnings per share estimates for shares of Cytosorbents in a research note issued to investors on Monday, November 11th. HC Wainwright analyst S. Lee now expects that the medical research companyNovember 14, 2024 | marketbeat.comCytoSorbents, Converge Biotech announce strategic partnershipNovember 12, 2024 | markets.businessinsider.comCytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.comNovember 12, 2024 | americanbankingnews.comCytoSorbents Hops on Alliance with ConvergeNovember 11, 2024 | baystreet.caBalanced Hold Rating Amid Revenue Miss and Strategic Initiatives at CytoSorbentsNovember 11, 2024 | markets.businessinsider.comCytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in IndiaNovember 11, 2024 | globenewswire.comCytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on shares of Cytosorbents in a research note on Sunday. They issued a "hold" rating on the stock.November 10, 2024 | marketbeat.comCytosorbents Corporation (CTSO) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comCytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ...November 9, 2024 | finance.yahoo.comCytoSorbents Corporation’s Q3 2024 Financial HighlightsNovember 8, 2024 | markets.businessinsider.comCytoSorbents Reports Third Quarter 2024 Financial and Operational ResultsNovember 7, 2024 | markets.businessinsider.comCytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of EarningsNovember 6, 2024 | finance.yahoo.comCytoSorbents submits Health Canada MDL application for DrugSorb ATRNovember 5, 2024 | markets.businessinsider.comCytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP CertificationNovember 5, 2024 | theglobeandmail.comCytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.comStockNews.com began coverage on shares of Cytosorbents in a report on Saturday. They issued a "hold" rating on the stock.November 2, 2024 | marketbeat.comCytosorbents (CTSO) Scheduled to Post Earnings on ThursdayCytosorbents (NASDAQ:CTSO) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636646)October 31, 2024 | marketbeat.comFDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive ReviewOctober 22, 2024 | markets.businessinsider.comCytoSorbents announces FDA has accepted De Novo medical device applicationOctober 22, 2024 | markets.businessinsider.comCytoSorbents to Report Third Quarter 2024 Operating and Financial ResultsOctober 18, 2024 | markets.businessinsider.comCytosorbents (NASDAQ:CTSO) Receives New Coverage from Analysts at StockNews.comStockNews.com assumed coverage on shares of Cytosorbents in a report on Thursday. They set a "hold" rating for the company.October 17, 2024 | marketbeat.comCytosorbents Co. (NASDAQ:CTSO) Sees Significant Decline in Short InterestCytosorbents Co. (NASDAQ:CTSO - Get Free Report) was the recipient of a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 1,330,000 shares, a decrease of 5.7% from the September 15th total of 1,410,000 shares. Based on an average daily trading volume, of 91,700 shares, the short-interest ratio is currently 14.5 days.October 16, 2024 | marketbeat.comCytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ...October 10, 2024 | finance.yahoo.comCytoSorbents Announces DrugSorb-ATR De Novo Submission To FDA - Quick FactsOctober 2, 2024 | markets.businessinsider.comCTSO: CytoSorbents Announces Submission of DrugSorb-ATR Application to the FDAOctober 2, 2024 | finance.yahoo.comCytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business UpdateOctober 1, 2024 | globenewswire.comCytosorbents (NASDAQ:CTSO) shareholders have endured a 81% loss from investing in the stock three years agoSeptember 30, 2024 | finance.yahoo.comCytosorbents (NASDAQ:CTSO) Shares Cross Above 200-Day Moving Average of $0.94Cytosorbents (NASDAQ:CTSO) Share Price Crosses Above 200 Day Moving Average of $0.94August 30, 2024 | marketbeat.comCytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment ConferenceAugust 27, 2024 | globenewswire.comCytosorbents Co. to Post Q3 2024 Earnings of ($0.09) Per Share, B. Riley Forecasts (NASDAQ:CTSO)Cytosorbents Co. (NASDAQ:CTSO - Free Report) - Research analysts at B. Riley reduced their Q3 2024 earnings per share estimates for shares of Cytosorbents in a report issued on Wednesday, August 14th. B. Riley analyst Y. Zhi now forecasts that the medical research company will earn ($0.09) per shAugust 19, 2024 | marketbeat.comCytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 16, 2024 | globenewswire.comCytosorbents Co. (NASDAQ:CTSO) Forecasted to Post Q3 2024 Earnings of ($0.05) Per ShareCytosorbents Co. (NASDAQ:CTSO - Free Report) - Investment analysts at HC Wainwright increased their Q3 2024 earnings per share estimates for Cytosorbents in a report issued on Wednesday, August 14th. HC Wainwright analyst S. Lee now forecasts that the medical research company will earn ($0.05) peAugust 16, 2024 | marketbeat.comCytosorbents Co. to Post Q1 2025 Earnings of ($0.02) Per Share, HC Wainwright Forecasts (NASDAQ:CTSO)Cytosorbents Co. (NASDAQ:CTSO - Free Report) - Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Cytosorbents in a research report issued to clients and investors on Wednesday, August 14th. HC Wainwright analyst S. Lee forecasts that the medical research coAugust 15, 2024 | marketbeat.comCytosorbents Corporation (CTSO) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comCytoSorbents Reports Second Quarter 2024 Financial and Operational ResultsAugust 13, 2024 | globenewswire.comCytoSorbents Appoints Peter J. Mariani Chief Financial OfficerAugust 13, 2024 | globenewswire.comCytosorbents earnings preview: what Wall Street is expectingAugust 12, 2024 | markets.businessinsider.comCytosorbents Q2 2024 Earnings PreviewAugust 12, 2024 | msn.comCytosorbents (CTSO) Set to Announce Earnings on TuesdayCytosorbents (NASDAQ:CTSO) will be releasing earnings after the market closes on Tuesday, August 13, Zacks reports.August 8, 2024 | marketbeat.comCytoSorbents to Report Second Quarter 2024 Operating and Financial ResultsAugust 7, 2024 | globenewswire.comCytoSorbents Announces Compliance with Nasdaq Minimum Bid Price RequirementAugust 1, 2024 | globenewswire.comCytoSorbents Unveils Newly Redesigned, Unified Company and Product WebsiteJuly 30, 2024 | globenewswire.comCytoSorbents Unveils Newly Redesigned, Unified Company and Product WebsiteJuly 29, 2024 | finance.yahoo.comCytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health CongressJuly 17, 2024 | globenewswire.comCytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving Average of $0.93Cytosorbents (NASDAQ:CTSO) Shares Cross Above 200 Day Moving Average of $0.93July 13, 2024 | marketbeat.comCytoSorbents Secures $20 Million Credit FacilityJuly 2, 2024 | globenewswire.comCytoSorbents to Host its 2024 Virtual Annual Stockholders MeetingJune 5, 2024 | globenewswire.comCTSO: CytoSorbents reports 1st quarter 2024 financial results and highlighted STAR-T trial data presentation at the AATS conference.May 15, 2024 | finance.yahoo.comCTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00May 15, 2024 | finance.yahoo.com Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. CTSO Media Mentions By Week CTSO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTSO News Sentiment▼-0.240.45▲Average Medical News Sentiment CTSO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTSO Articles This Week▼61▲CTSO Articles Average Week Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARAY News Today SKIN News Today PROF News Today SGHT News Today ZJYL News Today SONX News Today BWAY News Today DRTS News Today LAKE News Today NVRO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTSO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
